Sally Fischer | Principal Scientist And Group Leader

Sally Fischer, Principal Scientist And Group Leader, Genentech

Sally joined Genentech as a Research Scientist in 2000. She moved to Development Sciences department in 2003 and is currently a Senior Director & Senior Principal Scientist in the Assay Development and Technology (ADT) group within the Bioanalytical Sciences (BAS) department. Through the past 18 years, Sally has led a team that develops bioanalytical strategies to measure drug levels, assess immunogenicity and evaluate biomarkers using novel technologies to support Genentech studies and enable IND, BLA, NDA and related filings in support development of novel therapeutics in both immunology and neuroscience therapeutic areas in the Genentech development pipeline. Another area of focus in the past a few years has been evaluation and implementation of innovative patient centric healthcare solutions that have the potential to positively impact patient care and clinical trial timelines.


Festival of Biologics Day 3 @ 11:50

Next generation bioanalytics and impact on drug discovery/development: Microsampling & POC

last published: 31/Jan/23 09:55 GMT
last published: 31/Jan/23 09:55 GMT

back to speakers